This company listing is no longer active
Delta 9 Cannabis Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Delta 9 Cannabis.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 54.4% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Recent updates
It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year
Jun 21
It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks
May 10Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story
Mar 26Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost
Mar 26Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?
Sep 09Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%
Jul 28Does Delta 9 Cannabis (TSE:DN) Have A Healthy Balance Sheet?
Aug 19Is Delta 9 Cannabis (TSE:DN) A Risky Investment?
Jan 11Delta 9 Cannabis (TSE:DN) Is Making Moderate Use Of Debt
Sep 28Delta 9 Cannabis (TSE:DN) Is Carrying A Fair Bit Of Debt
Apr 08John Arbuthnot Is The Co-Founder of Delta 9 Cannabis Inc. (TSE:DN) And They Just Picked Up 1.0% More Shares
Dec 24
In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Delta 9 Cannabis onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 3/31/2024 | 71 | -20 | 4 | 4 | N/A |
| 12/31/2023 | 71 | -18 | 4 | 4 | N/A |
| 9/30/2023 | 71 | -22 | 4 | 5 | N/A |
| 6/30/2023 | 68 | -24 | 3 | 4 | N/A |
| 3/31/2023 | 68 | -26 | -3 | -1 | N/A |
| 12/31/2022 | 63 | -27 | -6 | -4 | N/A |
| 9/30/2022 | 63 | -21 | -7 | -5 | N/A |
| 6/30/2022 | 62 | -14 | -8 | -6 | N/A |
| 3/31/2022 | 62 | -11 | -4 | -1 | N/A |
| 12/31/2021 | 62 | -11 | -3 | -1 | N/A |
| 9/30/2021 | 59 | -8 | -6 | -2 | N/A |
| 6/30/2021 | 57 | -12 | -6 | -3 | N/A |
| 3/31/2021 | 54 | -13 | -7 | -2 | N/A |
| 12/31/2020 | 52 | -6 | -4 | 2 | N/A |
| 9/30/2020 | 48 | -8 | -6 | 0 | N/A |
| 6/30/2020 | 42 | -4 | -10 | 1 | N/A |
| 3/31/2020 | 38 | -3 | -16 | -3 | N/A |
| 12/31/2019 | 32 | 11 | -26 | -12 | N/A |
| 9/30/2019 | 26 | 12 | -34 | -10 | N/A |
| 6/30/2019 | 21 | 11 | -35 | -14 | N/A |
| 3/31/2019 | 13 | 10 | -35 | -15 | N/A |
| 12/31/2018 | 8 | -8 | -26 | -9 | N/A |
| 9/30/2018 | 3 | -12 | -16 | -11 | N/A |
| 6/30/2018 | 2 | -11 | -10 | -7 | N/A |
| 3/31/2018 | 1 | -9 | -7 | -5 | N/A |
| 12/31/2017 | 1 | -8 | N/A | -5 | N/A |
| 9/30/2017 | 1 | -2 | N/A | -3 | N/A |
| 6/30/2017 | 1 | -2 | N/A | -2 | N/A |
| 3/31/2017 | 1 | -1 | N/A | -1 | N/A |
| 12/31/2016 | 0 | -1 | N/A | -1 | N/A |
| 12/31/2015 | 1 | -1 | N/A | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if DN's forecast earnings growth is above the savings rate (2.2%).
Winst versus markt: Insufficient data to determine if DN's earnings are forecast to grow faster than the Canadian market
Hoge groeiwinsten: Insufficient data to determine if DN's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if DN's revenue is forecast to grow faster than the Canadian market.
Hoge groei-inkomsten: Insufficient data to determine if DN's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if DN's Return on Equity is forecast to be high in 3 years time